NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1031220071

Registered date:19/05/2022

Study comparing efficacy of two types of zoster vaccines in HIV positive people

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedzoster
Date of first enrollment19/05/2022
Target sample size200
Countries of recruitment
Study typeInterventional
Intervention(s)Participants will be allocated either to Shingrix (recombinant zoster vaccine/GSK) or Varicella vaccine (live attenuated vaccine/Takeda, Tanabe Mitsubishi, Osaka University).

Outcome(s)

Primary Outcomedeveloping zoster
Secondary Outcomeserum VAV-IgG titer and skin reaction to varicella virus antigen after the vaccination adverse events after the vaccination

Key inclusion & exclusion criteria

Age minimum>= 50age old
Age maximumNot applicable
GenderBoth
Include criteria1. 50 or over 50 years old 2. HIV positive with CD4 counts 200 or more than 200 per microliter 3. written informed consent
Exclude criteria1. history of severe allergic reaction to the vaccine ingredient 2. severely immunocompromised 3. history of vaccination against varicella or zoster within 5 years 4. reagarded as inappropriate by the study investigators

Related Information

Contact

Public contact
Name Yukihiro Yoshimura
Address 1-1 Mitsuzawanishi-cho Kanagawa-ku Yokohama city Kanagawa Kanagawa Japan 221-0855
Telephone +81-45-316-4580
E-mail yymolep@gmail.com
Affiliation Yokohama Mucnicipal CItizen's Hospital
Scientific contact
Name Yukihiro Yoshimura
Address 1-1 Mitsuzawanishi-cho Kanagawa-ku Yokohama city Kanagawa Kanagawa Japan 221-0855
Telephone +81-45-316-4580
E-mail yymole@gmailc.om
Affiliation Yokohama Municipal Citizen's Hospital